Nitroglycerin Lingual Spray (Nitrolingual Pumpspray) Interacts With Phosphodiesterase Inhibitors. ... Data from the seven-month Salmeterol Multicenter Asthma Research Trial ...

Sichuan Haisco Pharmaceutical Co. Ltd. has identified phosphodiesterase PDE3 and phosphodiesterase PDE4 inhibitors reported to be useful for the treatment of chronic obstructive pulmonary disease ...

WASHINGTON -- Treatment with the first-in-class dual phosphodiesterase 3/4 inhibitor ensifentrine reduced exacerbation rates and improved other key outcomes in patients with chronic obstructive ...

Matsuhira T, Nishiyama O, Tabata Y, et al. A novel phosphodiesterase 4 inhibitor, AA6216, reduces macrophage activity and fibrosis in the lung. Eur J Pharmacol 2020;885:173508-173508. Crossref.

Sildenafil is a preferential inhibitor of phosphodiesterase type 5 with a 50% inhibitory concentration of 3.5 nmol per liter for phosphodiesterase type 5, as compared with 50% inhibitory ...

Giving patients with chronic obstructive pulmonary disease (COPD) newly available oral phosphodiesterase 4 inhibitors, roflumilast or cilomilast, improves lung function and reduces the likelihood ...